Houston Rodeo’s Mission and Vision with Dr. Kelly Larkin

For over 90 years, the Houston Livestock Show and Rodeo has been a center of entertainment and sportsmanship. This event continues to be a hub of notable scholarships for college students and volunteering, particularly within the medical community. From injuries sustained by the rodeo athletes to preventive care and training, healthcare is a vital part of the rodeo experience.

What is the significance of the Houston Livestock Show and Rodeo and how does it shape the lives of the employees, volunteers, and people who attend the event?

On today’s episode of Highway to Health, host David Kemp talks with Dr. Kelly Larkin, the founder of the Sports Medicine Committee at the Houston Livestock Show and Rodeo, about the mission and impact of the Houston Livestock Show and Rodeo.

The two discuss:

  1. Kelly Larkin’s background in healthcare and how she came to be a part of the Houston Livestock Show and Rodeo scene
  2. The magnitude of the Houston Livestock Show and Rodeo and the multiple medical committees involved
  3. Houston Livestock Show and Rodeo’s offered scholarships, the importance of volunteers, and how teamwork effects everything

“We have scholarships for students going into Texas colleges, and they get a four-year scholarship,” Larkin said. “That’s the majority. We also do grants. We have grants that align with mission and vision of the rodeo. It may be a reading program, or it may be something else that goes along with youth and education and agriculture.”

Dr. Kelly Larkin is the founder of the Sports Medicine Committee at the Houston Livestock Show and Rodeo. Larkin is a board-certified emergency medicine physician and the Founder and President/CEO of The Larkin Group. Her specialty areas include Emergency Medicine, Healthcare Consulting, Healthcare Management, Medical Coding, Billing and Collection, EMS Transport Services, Healthcare Staffing, Physician Relations, and Medical Education.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…